Bipolar disorders

RS McIntyre, M Berk, E Brietzke, BI Goldstein… - The Lancet, 2020 - thelancet.com
Bipolar disorders are a complex group of severe and chronic disorders that includes bipolar
I disorder, defined by the presence of a syndromal, manic episode, and bipolar II disorder …

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

J Firth, N Siddiqi, AI Koyanagi, D Siskind… - The Lancet …, 2019 - thelancet.com
Background The poor physical health of people with mental illness is a multifaceted,
transdiagnostic, and global problem. People with mental illness have an increased risk of …

Incidence, prevalence, and global burden of schizophrenia-data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

M Solmi, G Seitidis, D Mavridis, CU Correll… - Molecular …, 2023 - nature.com
Schizophrenia substantially contributes to the burden of mental disorders. Schizophrenia's
burden and epidemiological estimates in some countries have been published, but updated …

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with …

T Pillinger, RA McCutcheon, L Vano, Y Mizuno… - The Lancet …, 2020 - thelancet.com
Background Antipsychotic treatment is associated with metabolic disturbance. However, the
degree to which metabolic alterations occur in treatment with different antipsychotics is …

Cardiovascular disease in patients with severe mental illness

RE Nielsen, J Banner, SE Jensen - Nature Reviews Cardiology, 2021 - nature.com
Individuals diagnosed with schizophrenia or bipolar disorder have a life expectancy 15–20
years shorter than that in the general population. The rate of unnatural deaths, such as …

The clinical characterization of the patient with primary psychosis aimed at personalization of management

M Maj, J van Os, M De Hert, W Gaebel… - World …, 2021 - Wiley Online Library
The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …

[HTML][HTML] Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends

M Sabe, T Pillinger, S Kaiser, C Chen, H Taipale… - Neuroscience & …, 2022 - Elsevier
Abstract Changes over 50 years of research on antipsychotics in schizophrenia have
occurred. A scientometric synthesis of such changes over time and a measure of …

Short‐chain fatty acids: microbial metabolites that alleviate stress‐induced brain–gut axis alterations

M Van de Wouw, M Boehme, JM Lyte… - The Journal of …, 2018 - Wiley Online Library
Key points Chronic (psychosocial) stress changes gut microbiota composition, as well as
inducing behavioural and physiological deficits. The microbial metabolites short‐chain fatty …

20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia …

H Taipale, A Tanskanen, J Mehtälä… - World …, 2020 - Wiley Online Library
Antipsychotics are effective in preventing relapses of schizophrenia, but it is generally
believed that their long‐term use is harmful for patients' physical well‐being. However, there …

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 …

CU Correll, M Solmi, N Veronese, B Bortolato… - World …, 2017 - Wiley Online Library
People with severe mental illness (SMI)–schizophrenia, bipolar disorder and major
depressive disorder–appear at risk for cardiovascular disease (CVD), but a comprehensive …